IL18 and acute kidney injury: Because some studies have shown that use of single biomarkers may not be adequate to determine whether AKI is due to kidney heterogeneity or various dysfunctions, we combined KIM-1 with IL-18 and clinical observations for early diagnosis of AKI in burn patients and rapid therapeutic interventions.